卓悅控股(00653.HK)主席遭副主席葉俊亨入稟追債 主席稱申索款項毫無根據
卓悅控股(00653.HK)公布,於6月8日公司主席兼執行董事陳健文(被告)收到代表葉俊亨之律師於香港高等法院原訟法庭所出具關於針對被告的傳訊令狀。原告為公司的副主席兼執行董事。
根據傳訊令狀,原告主張被告歸還7,500萬元的款項,即被告於2019年2月至7月期間的一系列原告授予被告的貸款項下應付的尚未償還款項或其他已持有及取得的款項。
陳健文發表聲明指,葉俊亨入稟提出申索款項毫無根據,且沒有理據支持。其正在就上述之申索尋求法律建議,為個人立場全力辯護,並保留一切法律權利向葉氏進行反索償;就任何蓄意或惡意損害其聲譽的行為,務必訴諸法律行動,追究到底。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.